Keros Therapeutics Inc (KROS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 8k | 143k | 83k |
| Operating Income | -30.73M | -27.98M | -31.96M | -38.87M | -41.34M | -43.28M | -46.46M | -48.48M |
| Pre Tax Income | -27.27M | -23.51M | -29.72M | -35.8M | -37.51M | -39.44M | -40.24M | -43.11M |
| Net Income | -27.27M | -23.51M | -29.72M | -35.8M | -37.51M | -39.44M | -40.24M | -43.11M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -27.33M | -23.51M | -29.72M | -35.8M | -37.51M | -39.44M | -55M | -48.92M |
| EBITDA | -30.42M | -27.85M | -31.81M | -38.7M | -41.15M | -43.07M | -46.21M | -48.21M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10M | 10M | 0 | 20.1M | 0 | 151k |
| Operating Income | -1.69M | -10.56M | -46.66M | -56.37M | -114.79M | -169.94M |
| Pre Tax Income | -1.08M | -12.34M | -45.53M | -56.73M | -104.68M | -152.99M |
| Net Income | -1.34M | -12.34M | -45.36M | -58.74M | -104.68M | -152.99M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.595 | -5.077 | -1.956 | -2.45 | -3.801 | -5.107 |
| EBIT | -1.08M | -12.33M | -45.53M | -56.73M | -104.68M | -167.75M |
| EBITDA | -1.54M | -10.36M | -46.38M | -56M | -114.09M | -169.13M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
